The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and Treatment
Abstract
In Brief Background: Polypoidal choroidal vasculopathy (PCV) is an exudative maculopathy affecting vision, with clinical features distinct from neovascular age-related macular degeneration. Currently, no evidence-based guidelines exist for its diagnosis and treatment. Methods: A panel of experts analyzed a systematic literature search on PCV together with results of the EVEREST trial, the only published randomized controlled clinical trial in PCV. At a subsequent Roundtable meeting, recommendations for the management of PCV were agreed based on this analysis and their own expert opinion. Results: Diagnosis of PCV should be based on early-phase nodular hyperfluorescence from choroidal vasculature visualized using indocyanine green angiography. Recommended initial treatment of juxtafoveal and subfoveal PCV is either indocyanine green angiography-guided verteporfin photodynamic therapy or verteporfin photodynamic therapy plus 3 × 0.5 mg ranibizumab intravitreal injections 1 month apart. If there is incomplete regression of polyps by indocyanine green angiography, eyes should be retreated with verteporfin photodynamic therapy monotherapy or verteporfin photodynamic therapy plus ranibizumab. If there is complete regression of polyps by indocyanine green angiography, but there is leakage on fluorescein angiography and other clinical or anatomical signs of disease activity, eyes should be retreated with ranibizumab. Conclusion: Practical guidance on the clinical management of PCV is proposed based on expert evaluation of current evidence. A panel of international experts convened a Roundtable meeting in Singapore in May 2010 to conclude discussions and agree consensus recommendations for the management of polypoidal choroidal vasculopathy. Practical guidance on the clinical management of polypoidal choroidal vasculopathy is proposed based on their evaluation of available evidence in conjunction with their own expert opinion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United Kingdom, ICGA is not available in all units and is usually reserved for cases presenting with clinical features suspicious of polypoidal choroidopathy (IPCV) or retinal angiomatous proliferation (RAP) or when response to anti-VEGF therapy is suboptimal.11,12”
From Defining response to anti-VEGF therapies in neovascular AMD (2015) · cites this paper as [12]
In the citing paper
“However, an expanding or increased elevation in PED indicates activity that merits evaluation and treatment.11,12”
From Defining response to anti-VEGF therapies in neovascular AMD (2015) · cites this paper as [12]
In the citing paper
“The EVEREST study suggested that combination therapy of IPCV with photodynamic therapy (PDT) and ranibizumab led to a better outcome than monotherapy with ranibizumab.11,12”
From Defining response to anti-VEGF therapies in neovascular AMD (2015) · cites this paper as [12]
In the citing paper
“Some lesion types are thought to be less responsive than others to anti-VEGF therapy, for example, IPCV.”
From Defining response to anti-VEGF therapies in neovascular AMD (2015) · cites this paper as [12]
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522 · cited 1×
“In cases where CNV coexists with PCV or where a differential diagnosis is difficult, combination therapy would ensure that the standard of care is met for both conditions.(168,169) In circumstances where there is leakage from both components of PCV or where there is extensive subretinal fluid or exudation associated w…”
BackgroundBrown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., & Ianchulev, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.018 · Cited by 1,318
Fluorescence Properties and Metabolic Features of Indocyanine Green (ICG) as Related to Angiography
Desmettre, T., Devoisselle, J. M., & Mordon, S. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00123-5 · Cited by 754
IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)
Yannuzzi, L. A., Sorenson, J., Spaide, R. F., & Lipson, B. (2012) · Retina · doi:10.1097/iae.0b013e31823f992a · Cited by 753
INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY
SPAIDE, R. F., YANNUZZI, L. A., SLAKTER, J. S., SORENSON, J., & ORLACH, D. A. (1995) · Retina · doi:10.1097/00006982-199515020-00003 · Cited by 608
IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)
YANNUZZI, L. A., SORENSON, J., SPAIDE, R. F., & LIPSON, B. (1990) · Retina · doi:10.1097/00006982-199010010-00001 · Cited by 588
Koh, A., Lee, W. K., Chen, L.-J., Chen, S.-J., Hashad, Y., Kim, H., Lai, T. Y., Pilz, S., Ruamviboonsuk, P., Tokaji, E., et al. (2012) · Retina · doi:10.1097/iae.0b013e31824f91e8 · Cited by 587
Self-citationClinical Characteristics of Exudative Age-related Macular Degeneration in Japanese Patients
Maruko, I., Iida, T., Saito, M., Nagayama, D., & Saito, K. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.03.047 · Cited by 544
Self-citationPolypoidal Choroidal Vasculopathy
Cheung, C. M. G., Lai, T. Y. Y., Teo, K., Ruamviboonsuk, P., Chen, S.-J., Kim, J. E., Gomi, F., Koh, A. H., Kokame, G., Jordan-Yu, J. M., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.08.006 · Cited by 519
Self-citation
Research works printed but not linked: 2
- Shah, 2011, Does laser still have a role in the management of retinal vascular and neovascular diseases Am J O, phthalmol, 152, 332
- Ahuja, 2000, . Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments., Br J Ophthalmol, 84, 479, 10.1136/bjo.84.5.479 · DOI
Cited by
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Daruich, A., Matet, A., Dirani, A., Bousquet, E., Zhao, M., Farman, N., Jaisser, F., & Behar-Cohen, F. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.05.003 · Cited by 989
Schmidt-Erfurth, U., Chong, V., Loewenstein, A., Larsen, M., Souied, E., Schlingemann, R., Eldem, B., Monés, J., Richard, G., & Bandello, F. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305702 · Cited by 639
Polypoidal Choroidal Vasculopathy
Cheung, C. M. G., Lai, T. Y. Y., Ruamviboonsuk, P., Chen, S.-J., Chen, Y., Freund, K. B., Gomi, F., Koh, A. H., Lee, W.-K., & Wong, T. Y. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2017.11.019 · Cited by 396
Self-citationDefining response to anti-VEGF therapies in neovascular AMD
Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S., Lotery, A., et al. (2015) · Eye · doi:10.1038/eye.2015.48 · Cited by 355
Koh, A., Lai, T. Y. Y., Takahashi, K., Wong, T. Y., Chen, L.-J., Ruamviboonsuk, P., Tan, C. S., Feller, C., Margaron, P., Lim, T. H., et al. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.4030 · Cited by 301
Self-citation
Metadata
- Authors
- Koh, A. H. C., Chen, L.-J., Chen, S.-J., Chen, Y., Giridhar, A., Iida, T., Kim, H., Lai, T. Y. Y., Lee, W. K., Li, X., Han Lim, T., Ruamviboonsuk, P., Sharma, T., Tang, S., & Yuzawa, M.
- Affiliations
- Eye & Retina Surgeons (SG)
- Mackay Memorial Hospital (TW)
- Taipei Veterans General Hospital (TW)
- Peking Union Medical College Hospital (CN)
- Fukushima Medical University (JP)
- Hallym University (KR)
- Chinese University of Hong Kong (HK)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Peking University (CN)
- Sankara Nethralaya (IN)
- Sun Yat-sen University (CN)
- Surugadai Nihon University Hospital (JP)
- Corresponding author
- Koh, Adrian H.C.
- Iida, Tomohiro
- Li, Xiaoxin
- Yuzawa, Mitsuko
- ORCID
- Venue
- Retina
- Published
- 2013-04
- Volume
- 33
- Issue
- 4
- Pages
- 686-716
- ISSN
- 0275-004X (ISSN-L)
- OpenAlex
- W2321748845
- Cited by
- 265
- References
- 176
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 9 · 2021: 20 · 2020: 17 · 2019: 25 · 2018: 29 · 2017: 30 · 2016: 30 · 2015: 37 · 2014: 20 · 2013: 11
- FWCI
- 32.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Retina (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Keywords
- polypoidal choroidal vasculopathy, exudative maculopathy, verteporfin photodynamic therapy, ranibizumab, indocyanine green angiography, EVEREST trial, retreatment, consensus recommendations
- MeSH terms
- Ranibizumab, Verteporfin, Choroid, Coloring Agents, Fluorescein Angiography, Humans, Indocyanine Green, Photochemotherapy, Polyps, Porphyrins, Choroid Diseases, Databases, Factual, Photosensitizing Agents, Evidence-Based Medicine, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and Treatment. https://app.cochat.ai/papers/10.1097/iae.0b013e3182852446
- The paper
- Koh, A. H. C., Chen, L.-J., Chen, S.-J., Chen, Y., Giridhar, A., Iida, T., Kim, H., Lai, T. Y. Y., Lee, W. K., Li, X., Han Lim, T., Ruamviboonsuk, P., Sharma, T., Tang, S., & Yuzawa, M. (2013). POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and Treatment. Retina. https://doi.org/10.1097/iae.0b013e3182852446
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.